Manhattan Scients
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The c… Read more
Market Cap & Net Worth: Manhattan Scients (MHTX)
Manhattan Scients (PINK:MHTX) has a market capitalization of $55.93K ($55.93K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #42406 globally and #13712 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Manhattan Scients's stock price $0.00 by its total outstanding shares 559281064 (559.28 Million).
Manhattan Scients Market Cap History: 2015 to 2025
Manhattan Scients's market capitalization history from 2015 to 2025. Data shows change from $37.98 Million to $55.93K (-51.58% CAGR).
Manhattan Scients Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Manhattan Scients's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
89.48x
Manhattan Scients's market cap is 89.48 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $37.98 Million | $64.00K | $8.01 Million | 593.36x | 4.74x |
| 2016 | $27.68 Million | $150.00K | -$6.11 Million | 184.56x | N/A |
| 2017 | $11.74 Million | $142.00K | $1.55 Million | 82.71x | 7.60x |
| 2019 | $5.87 Million | $97.00K | -$1.22 Million | 60.54x | N/A |
| 2020 | $23.88 Million | $50.00K | $4.31 Million | 477.63x | 5.54x |
| 2021 | $8.95 Million | $50.00K | -$3.64 Million | 178.97x | N/A |
| 2022 | $4.47 Million | $50.00K | -$2.73 Million | 89.48x | N/A |
Competitor Companies of MHTX by Market Capitalization
Companies near Manhattan Scients in the global market cap rankings as of March 18, 2026.
Key companies related to Manhattan Scients by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Manhattan Scients Historical Marketcap From 2015 to 2025
Between 2015 and today, Manhattan Scients's market cap moved from $37.98 Million to $ 55.93K, with a yearly change of -51.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $55.93K | -88.89% |
| 2024 | $503.35K | -65.38% |
| 2023 | $1.45 Million | -67.50% |
| 2022 | $4.47 Million | -50.00% |
| 2021 | $8.95 Million | -62.53% |
| 2020 | $23.88 Million | +306.67% |
| 2019 | $5.87 Million | +36.36% |
| 2018 | $4.31 Million | -63.33% |
| 2017 | $11.74 Million | -57.58% |
| 2016 | $27.68 Million | -27.10% |
| 2015 | $37.98 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Manhattan Scients was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $55.93K USD |
| MoneyControl | $55.93K USD |
| MarketWatch | $55.93K USD |
| marketcap.company | $55.93K USD |
| Reuters | $55.93K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.